Observation for the effect of Jiujiuchang probiotics for chemotherapy-induced diarrhea

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023622

Enrollment

Unknown

Registered

2019-06-04

Start date

2019-06-10

Completion date

Unknown

Last updated

2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy-induced diarrhea

Interventions

Experimental group:Probiotic “Jiujiuchang”

Control:Maltodextrin

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) aged equal to or over 18 years; (2) tumor patients with CID; (3) patients or family members sign informed consent file.

Exclusion criteria

Exclusion criteria: (1) serious heart, liver, lung or renal dysfunction; (2) gastroenterostomy or parenteral nutrition; (3) hospitalization time = 72h; (4) cachexy or disease which can cause hemolysis or hemoglobin <90g/L; (5) participating in other clinical trials; (6) Unwilling to cooperate.

Design outcomes

Secondary

Measure	Time frame
Intestinal barrier function;	—

Primary

Measure	Time frame
Gastrointestinal status score;	—

Countries

China

Contacts

Public ContactChen Gaiyun

The First Affiliated Hospital of Zhengzhou University

0371cgy@163.com+86 13526574489

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026